Cutting Edge: TNF-α Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation1

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Immunology

• Publication date

  2009-07-15

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.4049/jimmunol.0900173PMID 19542372PMCID PMC2754237
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Annexin-1 Regulates Macrophage IL-6 and TNF via Glucocorticoid-Induced Leucine Zipper1

  2009cited by this paper
• The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis

  2009cited by this paper
• MASP-1, a Promiscuous Complement Protease: Structure of Its Catalytic Region Reveals the Basis of Its Broad Specificity1

  2009cited by this paper
• Function of Nod‐like receptors in microbial recognition and host defense

  2009cited by this paper
• Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages.

  2009cited by this paper
• Progesterone Inhibits Activation-Induced Deaminase by Binding to the Promoter1

  2009cited by this paper
• How dying cells alert the immune system to danger

  2008cited by this paper
• The NALP3 inflammasome is involved in the innate immune response to amyloid-β

  2008cited by this paper
• Host innate immune receptors and beyond: making sense of microbial infections.

  2008cited by this paper
• ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1β and IL-18 secretion in an autocrine way

  2008cited by this paper
• Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production

  2008cited by this paper
• Monocytes from familial cold autoinflammatory syndrome patients are activated by mild hypothermia.

  2007cited by this paper
• Identification of a key pathway required for the sterile inflammatory response triggered by dying cells

  2007cited by this paper
• Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling.

  2007cited by this paper
• The inflammasome: a danger sensing complex triggering innate immunity.

  2007cited by this paper
• Differential Requirement of P2X7 Receptor and Intracellular K+ for Caspase-1 Activation Induced by Intracellular and Extracellular Bacteria*

  2007cited by this paper
• CATERPILLERs, pyrin and hereditary immunological disorders

  2006cited by this paper
• Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages

  2006cited by this paper
• Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3

  2006cited by this paper
• NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.

  2004cited by this paper
• Cutting Edge: CIAS1/Cryopyrin/PYPAF1/NALP3/ CATERPILLER 1.1 Is an Inducible Inflammatory Mediator with NF-κB Suppressive Properties

  2003cited by this paper
• Relationship between β-AP peptide aggregation and microglial activation

  2002cited by this paper
• Relationship between beta-AP peptide aggregation and microglial activation.

  2002cited by this paper
• Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in Vivo*

  1997cited by this paper
• Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo.

  1997cited by this paper
• Cytokine regulation of IL-1 beta gene expression in the human polymorphonuclear leukocyte.

  1990cited by this paper
• Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity

  1988cited by this paper
• Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

  1986cited by this paper

• Advances in understanding the role of NLRP3 inflammasome-mediated macrophage pyroptosis in the pathogenesis of silicosis.

  2026cites this paper
• Silibinin-loaded PEGylated niosomal nanoparticles restore hippocampus histological changes, memory and learning, and downregulate the inflammasome pathway in Alzheimer's disease animal models.

  2026cites this paper
• TPL2 kinase activity is required for Il1b transcription during LPS priming but dispensable for NLRP3 inflammasome activation

  2025cites this paper
• Restoring Homeostasis: Treating Amyotrophic Lateral Sclerosis by Resolving Dynamic Regulatory Instability

  2025cites this paper
• Updated insights into the molecular networks for NLRP3 inflammasome activation

  2025cites this paper
• Post-translational modifications of NLRP3: to prime or not to prime?

  2025cites this paper
• Targeting the NLRP3 inflammasome in sepsis: Molecular mechanisms and therapeutic strategies.

  2025cites this paper
• Pyroptosis in acute respiratory distress syndrome and pulmonary fibrosis.

  2025cites this paper
• Emodin Inhibits NLRP3 Inflammasome Activation and Protects Against Sepsis via Promoting FUNDC1-Mediated Mitophagy

  2025cites this paper
• Non-coding RNAs affecting NLRP3 inflammasome pathway in diabetic cardiomyopathy: a comprehensive review of potential therapeutic options

  2025cites this paper
• Cornuside alleviates cognitive impairments induced by Aβ1−42 through attenuating NLRP3-mediated neurotoxicity by promoting mitophagy

  2025cites this paper
• Inflammasomes and pyroptosis in cancer: mechanisms and therapeutic advances

  2025cites this paper
• cGAS–STING–NF-κB Axis Mediates Rotenone-Induced NLRP3 Inflammasome Activation Through Mitochondrial DNA Release

  2025cites this paper
• Mixed lineage kinase 3 contributes to myocardial ischemia/reperfusion injury by regulating neutrophil activation

  2025cites this paper
• Preclinical evidence and mechanistic insights of ligustilide in ischemic stroke: a systematic review and meta-analysis

  2025cites this paper
• Nitroxoline is a novel inhibitor of NLRP3-dependent pyroptosis

  2025cites this paper
• Association of Parvovirus B19 with NLRP3 Inflammasome in Cardiovascular Diseases

  2025cites this paper
• Molecular mechanisms and regulation of inflammasome activation and signaling: sensing of pathogens and damage molecular patterns

  2025cites this paper
• The NLRP3 inflammasome: a pivotal orchestrator of multisystem diseases—from molecular mechanisms to therapeutic innovation

  2025cites this paper
• The crosstalk of neutrophil extracellular trap-inflammasome and their roles in disease progression.

  2025cites this paper
• Progress in targeting the NLRP3 signaling pathway for inflammatory bowel disease (Review)

  2025cites this paper
• Activation and evasion of inflammasomes during viral and microbial infection

  2025cites this paper
• Innate Immune Mechanisms in Normal and Adverse Pregnancy.

  2025cites this paper
• Adaptations in mitochondrial quality control and interactions with innate immune signaling within skeletal muscle: A narrative review

  2025cites this paper
• Preclinical Evaluation of Baicalin for the Treatment of Diabetic Nephropathy: A Systematic Review and Meta-Analysis

  2025cites this paper
• The Effect of GB1 on DSS-Induced Colitis in WT and Nlrp3-/- Mice

  2025cites this paper
• The roles of microglia and astrocytes in neuroinflammation of Alzheimer’s disease

  2025cites this paper
• Loss of NKCC1 Activates the NLRP3 Inflammasome in Intestinal Epithelia

  2025cites this paper
• Targeting the NLRP3 inflammasome as a novel therapeutic target for osteoarthritis

  2025cites this paper
• Paeoniflorin inhibits the inflammation of rheumatoid arthritis fibroblast-like synoviocytes by downregulating hsa_circ_009012

  2024cites this paper
• NLRP3 inflammasome and its role in autoimmune diseases: A promising therapeutic target.

  2024cites this paper
• NLRP inflammasomes in health and disease

  2024cites this paper
• Dental Pulp Stem Cells Modulate Inflammasome Pathway and Collagen Deposition of Dermal Fibroblasts

  2024cites this paper
• Unmasking the NLRP3 inflammasome in dendritic cells as a potential therapeutic target for autoimmunity, cancer, and infectious conditions.

  2024cites this paper
• The non-pathogenic protozoon Leishmania tarentolae interferes with the activation of NLRP3 inflammasome in human cells: new perspectives in the control of inflammation

  2024cites this paper
• MicroRNA‐223 alleviates inflammatory response in renal ischemia‐reperfusion injury by targeting NLRP3

  2024cites this paper
• Differences in Cytokine Expression at Baseline and in Response to Mineral Stimulation by Peripheral Blood Mononuclear Cells from Podoconiosis Cases and Healthy Control Individuals

  2024cites this paper
• Inhibitors of NLRP3 Inflammasome Formation: A Cardioprotective Role for the Gasotransmitters Carbon Monoxide, Nitric Oxide, and Hydrogen Sulphide in Acute Myocardial Infarction

  2024cites this paper
• The pathogenesis of gout

  2024cites this paper
• The NLR family of innate immune and cell death sensors.

  2024cites this paper
• The role of cathelicidins in neutrophil biology.

  2024cites this paper
• Leveraging a comprehensive unbiased RNAseq database to characterize human monocyte-derived macrophage gene expression profiles within commonly employed in vitro polarization methods

  2024cites this paper
• The genetic advantage of healthy centenarians: unraveling the central role of NLRP3 in exceptional healthspan

  2024cites this paper
• Covalent Targeting As a Common Mechanism for Inhibiting NLRP3 Inflammasome Assembly.

  2024cites this paper
• The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBD

  2024cites this paper
• Hypoxia and TNF‐alpha modulate extracellular vesicle release from human induced pluripotent stem cell‐derived cardiomyocytes

  2024cites this paper
• Potential Impact of Bioactive Compounds as NLRP3 Inflammasome Inhibitors: An Update.

  2024cites this paper
• Balanced regulation of ROS production and inflammasome activation in preventing early development of colorectal cancer

  2024cites this paper
• Folic Acid Rescues Dopaminergic Neurons in MPTP-Induced Mice by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment.

  2024cites this paper
• Inflammasome activation in response to aberrations of cellular homeostasis in epithelial cells from human cornea and retina

  2024cites this paper
• The involvement of the Wnt/β-catenin signaling cascade in fibrosis progression and its therapeutic targeting by relaxin.

  2024cites this paper
• Co-adjuvanting Nod2-stimulating bacteria with a TLR7 agonist elicits potent protective immunity against respiratory virus infection.

  2024cites this paper
• DT-13 attenuates inflammation by inhibiting NLRP3-inflammasome related genes in RAW264.7 macrophages.

  2024cites this paper
• TLR priming licenses NAIP inflammasome activation by immunoevasive ligands

  2024cites this paper
• Exploring the correlation between innate immune activation of inflammasome and regulation of pyroptosis after intracerebral hemorrhage: From mechanism to treatment.

  2024cites this paper
• Implication of the LRR Domain in the Regulation and Activation of the NLRP3 Inflammasome

  2024cites this paper
• Knockout of hexokinase 2 regulates mitochondrial dysfunction and activates the NLRP3 signal pathway in the rumen epithelial cells of dairy cows.

  2024cites this paper
• The effects of NLRP3 rs10754558 and rs4612666 polymorphisms on preeclampsia susceptibility, onset, and severity: a case-control study and in silico analysis

  2024cites this paper
• Mechanistic insights from inflammasome structures

  2024cites this paper
• Ketone body metabolism and the NLRP3 inflammasome in Alzheimer's disease

  2024cites this paper
• From periphery to center stage: 50 years of advancements in innate immunity

  2024cites this paper
• SERTAD1 initiates NLRP3-mediated inflammasome activation through restricting NLRP3 polyubiquitination.

  2024cites this paper
• Unraveling the role of NLRP3 inflammasome in allergic inflammation: implications for novel therapies

  2024cites this paper
• Mitochondrial damage and clearance in retinal pigment epithelial cells

  2024cites this paper
• The NLRP3 inflammasome in viral infection (Review)

  2023cites this paper
• The molecular mechanisms underlying anti‐inflammatory effects of galangin in different diseases

  2023cites this paper
• A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases.

  2023cites this paper
• Covalent targeting as a common mechanism for inhibiting NLRP3 inflammasome assembly

  2023cites this paper
• Inflammasomes: Mechanisms of Action and Involvement in Human Diseases

  2023cites this paper
• Advances in NLRP3 Inflammatory Vesicles and Insulin Resistance

  2023cites this paper
• The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy

  2023cites this paper
• A TNF-IL-1 circuit controls Yersinia within intestinal granulomas

  2023cites this paper
• TLR priming licenses NAIP inflammasome activation by immunoevasive ligands

  2023cites this paper
• Mitochondrial damage activates the NLRP10 inflammasome

  2023cites this paper
• Tectorigenin inhibits inflammation in keratinocytes by inhibition of NLRP3 inflammasome regulated by the TLR4/NF-κB pathway.

  2023cites this paper
• NOD-like Receptors—Emerging Links to Obesity and Associated Morbidities

  2023cites this paper
• Advances on the early cellular events occurring upon exposure of human macrophages to aluminum oxyhydroxide adjuvant

  2023cites this paper
• Involvement of inflammasomes in tumor microenvironment and tumor therapies

  2023influential citation
• Water-Dispersible Fluorescent Silicon Nanoparticles That Modulate Inflammatory Response in Macrophages

  2023cites this paper
• Inhibition of CD82 improves colitis by increasing NLRP3 deubiquitination by BRCC3

  2023cites this paper
• Relationship between pyroptosis-mediated inflammation and the pathogenesis of prostate disease

  2023cites this paper
• Silicon dioxide-induced endoplasmic reticulum stress of alveolar macrophages and its role on the formation of silicosis fibrosis: a review article.

  2023cites this paper
• Mesenchymal stem cells attenuate systemic lupus erythematosus by inhibiting NLRP3 inflammasome activation through Pim-1 kinase.

  2023cites this paper
• Molecular mechanism of NR4A1/MDM2/P53 signaling pathway regulation inducing ferroptosis in renal tubular epithelial cells involved in the progression of renal ischemia-reperfusion injury.

  2023cites this paper
• The Potential of NLRP3 Inflammasome as a Therapeutic Target in Neurological Diseases

  2023cites this paper
• Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase

  2023cites this paper
• Multiple TLRs elicit alternative NLRP3 inflammasome activation in primary human monocytes independent of RIPK1 kinase activity

  2023cites this paper
• Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors.

  2023cites this paper
• NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors

  2023cites this paper
• Lipin‐2 regulates the antiviral and anti‐inflammatory responses to interferon

  2023cites this paper
• Type 1 invariant natural killer T cells in chronic inflammation and tissue fibrosis

  2023cites this paper
• NLRP3 inhibition leads to impaired mucosal fibroblast function in patients with inflammatory bowel diseases.

  2023cites this paper
• Accelerated NLRP3 inflammasome-inhibitory peptide design using a recurrent neural network model and molecular dynamics simulations

  2023cites this paper
• Leptospira interrogans Prevents Macrophage Cell Death and Pyroptotic IL-1β Release through Its Atypical Lipopolysaccharide.

  2023cites this paper
• Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction

  2023cites this paper
• New Potentiality of Bioactive Substances: Regulating the NLRP3 Inflammasome in Autoimmune Diseases

  2023cites this paper
• Collab or Cancel? Bacterial Influencers of Inflammasome Signaling.

  2023cites this paper
• Estrogen plays an important role by influencing the NLRP3 inflammasome.

  2023cites this paper
• Cis-urocanic acid improves cell viability and suppresses inflammasome activation in human retinal pigment epithelial cells.

  2023cites this paper
• Polyguluronic acid alleviates doxorubicin-induced cardiotoxicity by suppressing Peli1-NLRP3 inflammasome-mediated pyroptosis.

  2023cites this paper